COVID-19病人使用氣霧治療之臨床策略

Practical strategies for administering aaerosol drugs therapy to patients with COVID-19

王思惠(Ssu-Hui Wang) ； 林蕙鈴(Hui-Ling Lin) ； 劉瑞芳(Jui-Fang Liu) ； 翁靜美(Ching-Mei Weng) ； 蔣麗靜(Li-ching Chiang) ； 曾靜菀(Ching-wan Tseng)

《呼吸治療》 21卷1期 (2022/01) Pp. 15-25

https://doi.org/10.6269/JRT.202201_21(1).0002

摘要

臨床專家及學者認為新型冠狀病毒感染症（Coronavirus disease 2019，COVID-19）會透過飛沫及接觸傳染，但對於是否為空氣傳染仍持著保守態度。2020年7月世界衛生組織（World Health Organization，WHO）表示COVID-19在密集、密閉、通風不良環境中可能會有空氣傳播的危害。醫療人員執行會暴露於易產生生物氣膠（bioaerosol）的處置時，稱為氣膠生成醫療處置（aerosol-generating medical procedures，AGMPs），如氣管內管插管、痰液抽吸、支氣管鏡檢及呼吸治療師照護項目之一的氣霧治療（aerosol drugs therapy）等，受到感染的風險可能會增加，應特別加強防護。因此，本文將運用文獻回顧探討SARS-CoV-2傳播方式及進行氣霧治療時的臨床照護重點，以提供臨床醫療人員重要參考。

關鍵字

新型冠狀病毒感染症 ； 生物氣膠 ； 氣霧治療 ； 噴霧器 ； 氣膠生成醫療處置

並列摘要

The transmission pathway of Coronavirus disease clinical research is most likely through droplets or contact, and it has not yet been confirmed as airborne transmission. In July 2020, the World Health Organization (WHO) stated that the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) could be transmitted through the air in crowded, closed, and poorly ventilated environments. Healthcare workers are at a high risk of exposure to bioaerosols generated by infected patients when performing Aerosol-generating medical procedures. The WHO has indicated intubation, suctioning, and bronchoscopy as Aerosol-generating medical procedures. Aerosol therapy is classified as an aerosol-dispersing procedure, wherein the aerosol dispersion distance in the surrounding environment is increased. This review article aimed to explore the transmission pathways of SARS-CoV-2 and provide practical strategies for the administration of Aerosol therapy.

並列關鍵字

Coronavirus disease 2019 (COVID-19) ； Bioaerosol ； Aerosol drugs therapy ； Nebulizer ； aerosol-generating medical procedures (AGMPs)